RADCOM (RDCM) director Bennun reports 82,340 shares and options in Form 3
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
RADCOM LTD director Rachel (Heli) Bennun filed an initial Form 3 reporting her equity holdings in the company. She directly holds 82,340 Ordinary Shares, reflecting her existing ownership stake.
She also holds share options over 14,960 Ordinary Shares and a separate grant over 10,668 Ordinary Shares, each with an exercise price of $10.01 per share and an expiration date of October 15, 2034. Footnotes note one option grant was fully vested as of June 30, 2025, while another vests monthly from July 15, 2025 until October 15, 2026, and that her position includes 2,000 Ordinary Shares issuable upon vesting of restricted share units on a monthly schedule until July 21, 2026.
Positive
- None.
Negative
- None.
Insider Trade Summary
3 transactions reported
Mixed
3 txns
Insider
Bennun Rachel (Heli)
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Share Options (right to buy) | -- | -- | -- |
| holding | Share Options (right to buy) | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Share Options (right to buy) — 14,960 shares (Direct);
Ordinary Shares — 82,340 shares (Direct)
Footnotes (1)
- Includes a total amount of 2,000 Ordinary Shares issuable upon the vesting of restricted share units on a monthly basis until July 21, 2026. The options were granted on October 15, 2024, and are fully vested as of June 30, 2025. The options were granted on October 15, 2024, and vest on a monthly basis, beginning July 15, 2025, until October 15, 2026.
Key Figures
Direct Ordinary Shares: 82,340 shares
Option underlying shares (grant 1): 14,960 shares at $10.01
Option underlying shares (grant 2): 10,668 shares at $10.01
+2 more
5 metrics
Direct Ordinary Shares
82,340 shares
Ordinary Shares held directly as reported in Form 3
Option underlying shares (grant 1)
14,960 shares at $10.01
Share options over Ordinary Shares, expiring October 15, 2034
Option underlying shares (grant 2)
10,668 shares at $10.01
Share options over Ordinary Shares, expiring October 15, 2034
RSUs scheduled to vest
2,000 shares
Ordinary Shares issuable on monthly RSU vesting until July 21, 2026
Option expiration date
October 15, 2034
Expiration for reported share option grants
Key Terms
Form 3, Share Options (right to buy, restricted share units, vested
4 terms
Form 3 regulatory
"Director Rachel (Heli) Bennun filed an initial Form 3 reporting her equity holdings"
Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.
vested financial
"one option grant was fully vested as of June 30, 2025, while another vests monthly"
FAQ
What does the RADCOM (RDCM) Form 3 filed by Rachel (Heli) Bennun show?
The Form 3 shows director Rachel (Heli) Bennun’s initial ownership in RADCOM, including 82,340 Ordinary Shares, option grants over additional shares at $10.01 per share, and restricted share units scheduled to vest monthly through mid-2026.
What stock options are reported for Rachel (Heli) Bennun in RADCOM (RDCM)?
She holds share options linked to 14,960 and 10,668 underlying Ordinary Shares, each with a $10.01 exercise price and October 15, 2034 expiration. One grant was fully vested by June 30, 2025, and another vests monthly between July 2025 and October 2026.
Does the RADCOM (RDCM) Form 3 indicate recent buying or selling by Bennun?
No specific buy or sell transactions are indicated. The entries are classified as holdings, outlining Bennun’s existing Ordinary Shares, option awards, and restricted share units rather than new market purchases or sales of RADCOM stock.